Personalis, Inc. - Common Stock (PSNL)
4.1400
0.00 (0.00%)
Personalis Inc is a biotechnology company that specializes in advanced genomics and personalized medicine
The firm focuses on providing comprehensive genomic profiling services to aid in the detection and treatment of cancer. Through its proprietary technologies, Personalis analyzes a patient's unique genetic makeup to deliver insights that support personalized therapeutic decisions and improve patient outcomes. The company's offerings are aimed at healthcare providers, researchers, and pharmaceutical companies seeking to leverage genomic data for better understanding and addressing complex diseases, particularly in oncology.
